Literature DB >> 16168398

Immunochemical analysis of CD107a (LAMP-1).

Emma J Parkinson-Lawrence1, Caroline J Dean, Melissa Chang, John J Hopwood, Peter J Meikle, Doug A Brooks.   

Abstract

CD107a, also known as the lysosome associated membrane protein-1 (LAMP-1), is expressed largely in the endosome-lysosome membranes of cells, but is also found on the plasma membrane (1-2% of total LAMP-1). LAMP-1 has been implicated in a variety of cellular functions, including cancer metastasis. It has been proposed as a therapeutic agent for some cancers, and is a marker for lysosomal storage disorders and different cell types such as cytotoxic T cells. In light of this diversity of applications, it is important to have well characterized immune-reagents for the detection and quantification of LAMP-1. We have compared a new monoclonal antibody 80280 against LAMP-1 to an existing monoclonal antibody BB6 and a rabbit polyclonal antibody. While all antibodies gave similar results by immunofluorescence, the monoclonal antibody 80280 showed no epitope reactivity to LAMP-1 peptides, suggesting the possibility of a carbohydrate epitope. Western blotting revealed a weaker activity of the monoclonal antibody 80280 relative to either the BB6 monoclonal or the polyclonal antibodies. The monoclonal antibody 80280 is distinct from BB6, providing an additional reagent for CD107a analysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16168398     DOI: 10.1016/j.cellimm.2005.08.024

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomas.

Authors:  Stine S Jensen; Charlotte Aaberg-Jessen; Karina G Christensen; Bjarne Kristensen
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

2.  Lysosome imaging in cancer cells by pyrene-benzothiazolium dyes: An alternative imaging approach for LAMP-1 expression based visualization methods to avoid background interference.

Authors:  Chathura S Abeywickrama; Kaveesha J Wijesinghe; Robert V Stahelin; Yi Pang
Journal:  Bioorg Chem       Date:  2019-07-24       Impact factor: 5.275

3.  Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response.

Authors:  Pawel Mroz; Angelika Szokalska; Mei X Wu; Michael R Hamblin
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

Review 4.  Fate of Antibody-Drug Conjugates in Cancer Cells.

Authors:  Cécile Chalouni; Sophia Doll
Journal:  J Exp Clin Cancer Res       Date:  2018-02-06

5.  LAMP1 expression is associated with poor prognosis in breast cancer.

Authors:  Qingqing Wang; Juan Yao; Qin Jin; Xudong Wang; Huijun Zhu; Fan Huang; Wei Wang; Jianfeng Qiang; Qichao Ni
Journal:  Oncol Lett       Date:  2017-08-16       Impact factor: 2.967

6.  Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma.

Authors:  Yaping Long; Zihe Gao; Xiao Hu; Feng Xiang; Zhaozhen Wu; Jiahui Zhang; Xiao Han; Liyong Yin; Junfang Qin; Lan Lan; Fuzai Yin; Yue Wang
Journal:  Cancer Med       Date:  2018-07-26       Impact factor: 4.452

7.  Overexpression of Lysosome-Associated Membrane Protein 1 in Oral Squamous Cell Carcinoma and its Correlation with Tumor Differentiation and Metastasis.

Authors:  Mohammad Ali Ranjbar; Maryam Jamshidi
Journal:  Iran J Otorhinolaryngol       Date:  2022-01

8.  Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer.

Authors:  Atsushi Okato; Yusuke Goto; Akira Kurozumi; Mayuko Kato; Satoko Kojima; Ryosuke Matsushita; Masaya Yonemori; Kazutaka Miyamoto; Tomohiko Ichikawa; Naohiko Seki
Journal:  Int J Oncol       Date:  2016-05-16       Impact factor: 5.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.